Microvast (NASDAQ:MVST – Get Free Report) posted its earnings results on Monday. The company reported ($0.20) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.22), FiscalAI reports. The company had revenue of $45.81 million during the quarter, compared to analysts’ expectations of $80.25 million. Microvast had a negative return on equity of 10.34% and a net margin of 13.95%.
Here are the key takeaways from Microvast’s conference call:
- Q3 revenue fell 62.8% year over year as sales volume dropped amid weaker demand in Europe and APAC and lower U.S. sales. Gross margin declined to 5.2% from 37.6%, reflecting inventory write-downs, lower volume, and continued pricing pressure.
- Microvast reported a $76.8 million GAAP net loss and negative $60.8 million adjusted EBITDA for the quarter; it also recorded $35.7 million in non-cash asset impairments. Cash and restricted cash ended the quarter at $124.4 million after falling $44.8 million over nine months.
- Management said substantial doubt about the company’s ability to continue as a going concern remains, with significant near-term debt maturities and lender negotiations underway. The company is pursuing cost cuts, reduced capital spending, and potential asset sales, but said there is no assurance these efforts or debt negotiations will succeed.
- Microvast completed installation and commissioning of its Huzhou Phase 3.2 production equipment, but ramp-up depends on demand, qualification, yields, efficiency, and working capital; the line may operate below capacity without a significant volume increase. Solid-state and silicon-sulfur prototypes showed preliminary lab progress, but remain early-stage and require further validation and scale-up.
Microvast Stock Down 64.7%
Shares of MVST stock traded down $0.40 on Tuesday, reaching $0.22. 14,397,877 shares of the stock were exchanged, compared to its average volume of 4,795,898. The company has a current ratio of 1.09, a quick ratio of 0.82 and a debt-to-equity ratio of 0.03. Microvast has a twelve month low of $0.21 and a twelve month high of $4.98. The company has a market capitalization of $84.13 million, a price-to-earnings ratio of -10.90 and a beta of 3.72. The business’s 50 day moving average price is $0.61 and its 200 day moving average price is $1.33.
Microvast News Roundup
Here are the key news stories impacting Microvast this week:
- Positive Sentiment: Cantor Fitzgerald lowered its price target to $2.00 but maintained an Overweight rating. The target remains well above the cited $0.22 share price, though the reduction itself signals a less favorable outlook. TickerReport article
- Positive Sentiment: Microvast completed installation and commissioning of production equipment at its Huzhou facility, and its Clarksville pack assembly line is substantially complete. These facilities could support future output, but ramp-up depends on demand, financing and operational execution. Q3 results release
- Neutral Sentiment: The company is cutting costs, limiting discretionary spending and negotiating with lenders to refinance, extend or restructure debt. It has refinanced some borrowings, but says there is no assurance that additional refinancing will be secured on acceptable terms. Cost-cutting and liquidity report
- Negative Sentiment: Q3 revenue fell 62.8% year over year to $45.8 million, well below the cited $80.25 million analyst consensus. Microvast posted a $76.8 million net loss, or $0.20 per share, versus a $1.5 million loss a year earlier; gross margin dropped to 5.2%, partly due to inventory write-downs and pricing pressure. Q3 earnings report
- Negative Sentiment: Liquidity is a major risk: Microvast said available cash may be insufficient to cover obligations over the next 12 months without financing, debt relief or further cost cuts, and concluded substantial doubt about its ability to continue as a going concern remains. Softer commercial-vehicle demand and a planned increase in China’s lithium battery consumption tax add to the challenges. Results and going-concern report
Analysts Set New Price Targets
MVST has been the subject of a number of recent research reports. Weiss Ratings restated a “sell (d+)” rating on shares of Microvast in a research note on Wednesday, November 4th. HC Wainwright lowered their price target on Microvast to $4.00 and set a “buy” rating on the stock in a report on Thursday, August 13th. Cantor Fitzgerald reduced their price target on shares of Microvast to $2.00 and set an “overweight” rating on the stock in a research report on Tuesday. Finally, Zacks Research raised shares of Microvast from a “strong sell” rating to a “hold” rating in a research note on Monday, July 13th. Two research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $3.00.
Check Out Our Latest Stock Report on Microvast
About Microvast
Microvast Holdings, Inc develops and manufactures lithium-ion battery technologies and energy storage solutions. The company offers battery cells, modules and packs, along with related battery components and systems designed for commercial vehicles, specialty vehicles, passenger vehicles and stationary energy storage applications.
Microvast emphasizes a vertically integrated approach that spans battery materials, cell development, manufacturing and system integration. Its product portfolio includes battery technologies based on different chemistries and form factors, allowing it to serve applications with varying requirements for energy density, power, safety, charging performance and operating life.
Founded in 2006 and headquartered in Stafford, Texas, Microvast serves customers in the United States, Europe and Asia.
Featured Articles
- Five stocks we like better than Microvast
- Axon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
Receive News & Ratings for Microvast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microvast and related companies with MarketBeat.com's FREE daily email newsletter.
